- Lyra Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- Lyra Therapeutics Inc at HC Wainwright Investment Conference - New York TranscriptSep 13, 2023
- Lyra Therapeutics Inc to discuss the topline results of the BEACON study Call TranscriptSep 12, 2023
- Lyra Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Lyra Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Lyra Therapeutics Inc at Jefferies London Healthcare Conference TranscriptNov 17, 2022
- Lyra Therapeutics Inc at Stifel Healthcare Conference TranscriptNov 15, 2022
- Lyra Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 14, 2022
- Lyra Therapeutics Inc Annual Shareholders Meeting TranscriptJun 16, 2022
- Lyra Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Lyra Therapeutics Inc at William Blair Growth Stock Conference TranscriptJun 06, 2022
- Lyra Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q3 2021 Lyra Therapeutics Inc Earnings Call TranscriptNov 09, 2021$6.79 (-3.69%)Earnings
- Q2 2021 Lyra Therapeutics Inc Earnings Call TranscriptAug 09, 2021$6.69 (-4.02%)Earnings
- Lyra Therapeutics Inc at William Blair Biotech Focus Conference (Virtual) TranscriptJul 15, 2021
- Lyra Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q4 2020 Lyra Therapeutics Inc Earnings Call TranscriptMar 09, 2021$14.6 (+2.17%)Earnings
- Lyra Therapeutics Inc in Maria Palasis & Strong Leadership in HealthTech TranscriptOct 08, 2020
- Q2 2020 Lyra Therapeutics Inc Earnings Call TranscriptAug 05, 2020$13.96 (+1.68%)Earnings
Q3 2021 Lyra Therapeutics Inc Earnings Call Transcript
Good day and thank you for standing by. Welcome to the Lyra Therapeutics third quarter financial review and operational highlights conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. (Operator Instructions) Now I'll turn the call over to Stephanie Marks with Argot Partners.
Thank you, operator. And welcome, everyone, to today's call. With me today are Dr. Maria Palasis, Lyra's President and Chief Executive Officer; Jason Cavalier, Chief Financial Officer; Dr. Robert Kern, Chief Medical Officer; and Corrine Noyes, SVP of Commercial Strategy and Market Development.
This afternoon, Lyra issued a press release announcing its third quarter 2021 Financial Results and Business Update. A copy of the announcement can be found in the Investor Relations tab of the company's website, lyratherapeutics.com. During the conference call, management will make forward-looking statements, including statements related to the clinical
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)